Gene expression can be post-transcriptionally regulated via dynamic and reversible RNA modifications. 
INTRODUCTION
More than 100 different types of post-transcriptional modifications have been identified so far (Machnicka et al., 2013) . Recent breakthroughs in sequencing technologies have greatly advanced our understanding of the location, regulation, and function of RNA modifications in the transcriptome (Frye et al., 2016; Fu et al., 2014; Helm and Motorin, 2017; Li et al., 2016b) , leading to the emerging field of epitranscriptomics (He, 2010; Saletore et al., 2012) . One such example is N 1 -methyladenosine (m 1 A), a prevalent modification in non-coding RNA (ncRNA) and messenger RNA (mRNA) (Anderson and Droogmans, 2005; Dominissini et al., 2016; Li et al., 2016a; Roundtree et al., 2017) . m 1 A was first documented more than 50 years ago (Dunn, 1961) ; later it was found to be a primordial RNA modification across the three major phylogenetic domains (Machnicka et al., 2013) . In human cells, m 1 A is found at positions 9 and 58 of human mitochondrial and cytoplasmic tRNAs, catalyzed by TRMT10C, TRMT61B, and TRMT6/61A, respectively (Chujo and Suzuki, 2012; Ozanick et al., 2005; Vilardo et al., 2012) ; it is also present at position 1322 of 28S rRNA, catalyzed by NML (Waku et al., 2016) . Its unique physicochemical property has endowed m 1 A with pivotal roles in maintaining the proper structure and function of these ncRNAs (Roundtree et al., 2017) . m 1 A in tRNA has been systematically evaluated by microarray and sequencing (Cozen et al., 2015; Saikia et al., 2010; Zheng et al., 2015) ; more recently, m 1 A58 is shown to be reversible by ALKBH1, demonstrating an example of reversible tRNA modification in translation regulation (Liu et al., 2016) . In addition to ncRNAs, m 1 A is also found to be a dynamic modification in mammalian mRNA, with strong enrichment in the 5 0 UTR Li et al., 2016a ). Despite such rapid progress, a high-resolution profile of the mammalian m 1 A methylome is still lacking, significantly limiting our understanding and functional characterization of this newly discovered mRNA modification. Previous m 1 A profiling technologies have a resolution of about tens of nucleotides to several hundred nucleotides, primarily determined by the size of RNA fragments in these experiments Li et al., 2016a) . In addition, the methyltransferase(s) and functional consequence of mRNA m 1 A modification are poorly understood. Hence, except for a handful positions in rRNA and tRNA, little is known about the precise location, regulation, and function of m 1 A in the human transcriptome. Here, we report a base-resolution method to profile m 1 A in the human transcriptome. Our method is based on m 1 A-induced misincorporation during reverse transcription and reveals distinct classes of m 1 A methylome: a major group of m 1 A sites that are enriched in 5 0 UTR, a small subset of GUUCRA (''R'' denotes a purine)-transfer RNA (tRNA)-like m 1 A sites with relatively even distribution in the transcriptome, and prevalent m 1 A modification in the coding sequence (CDS) of 10 of 13 mitochondrial-encoded transcripts. m 1 A sites in the 5 0 UTR, particularly those located at the first and second nucleotide of mRNA transcripts (or ''cap+1'' and ''cap+2'' positions) , are associated with increased translation efficiency. In contrast, m 1 A in the CDS of mt-mRNA inhibits translation. Collectively, our approaches reveal distinct classes of base-resolution m 1 A methylome in the nuclear-and mitochondrial-encoded transcripts and provide an in-depth resource toward elucidating the functions of m 1 A methylation in mRNA.
DESIGN
Because m 1 A can cause both truncation and misincorporation during cDNA synthesis (Hauenschild et al., 2015; Zubradt et al., 2017) , we first established the truncation and mutation profiles of different reserve transcriptases (RTases). We systematically compared the performance of several commercially available RTases (including AMV, SuperScript II, SuperScript III, and TGIRT) under different conditions ( Figure S1 ). We found that m 1 A can precisely induce misincorporation at the site of modification, while m 1 A-induced truncation is less accurate and can occur to the neighboring nucleotides. In addition, the truncation profile could be complicated by RNA secondary structures and the fragmentation process needed for library preparation. We concluded that the mutation profile contains a higher signal-to-noise ratio and is more precise in detecting the exact position of m 1 A. Among the RTases we tested, TGIRT demonstrated excellent readthrough efficiency and relatively high mutation frequency at the site of m 1 A ( Figure S1B ), consistent with the recent dimethyl sulfate mutational profiling with sequencing (DMS-MaPseq) and demethylase-thermostable group II intron RT tRNA sequencing (DM-tRNA-seq) results (Zheng et al., 2015; Zubradt et al., 2017) . Moreover, we employed a ligation-based strand-specific library preparation protocol (Van Nostrand et al., 2016) , which ensures that the m 1 A-induced mutation is within the sequenced fragment (see STAR Methods). Because we only observed $40%-50% mutation rate at m 1 A1322 in 28S rRNA ( Figure S2A ), which is known to be of high modification level, we further examined the quantitative capability of TGIRT. We chemically synthesized two model RNA sequences with site-specific m 1 A modification. For m 1 A sites with $97%-98% modification level (measured by quantitative mass spectrometry) ( Figure S2B ), we consistently observed $66%-75% misincorporation ( Figure S2C) ; the mismatch rate dropped non-linearly when we gradually lowered the modification level. Even with $50% m 1 A modification, a mismatch rate of only $9%-10% was observed ( Figure S2C ). These findings suggest that the observed mutation rate is an underestimation of the actual modification level. While the TGIRT-based procedure can still detect m 1 A sites of high modification level, sequencing RNA directly with TGIRT may not be able to capture the m 1 A sites with averaging modification level in the transcriptome ($20% as previously measured by microarray) . To improve the sensitivity for transcriptome-wide m 1 A detection, we decided to couple the TGIRTbased procedure with an antibody-mediated pre-enrichment step and an additional in vitro demethylation step ( Figure 1A ). We first showed that in vitro demethylation reaction mediated by the demethylase AlkB is more efficient than the Dimroth reaction, demonstrating $98% and $80% efficiency ( Figure S2D ), respectively. In addition, the extended treatment of RNA in alkaline condition during the Dimroth reaction leads to excessive RNA degradation ( Figure S2E) (Anderson and Droogmans, 2005) . m 1 A14 has been reported only in tRNA Phe and is considered to be very rare (Machnicka et al., 2013) ; we did not observe any m 1 A modification at position 14 for cytosolic tRNAs in HEK293T cells (Table S1 ). m 1 A58 is conserved across the three domains of life; previous tRNA microarray and sequencing data have reported hypomodified tRNAs at this position (Cozen et al., 2015; Saikia et al., 2010; Zheng et al., 2015) . Our results confirmed that m 1 A58 is globally present in the cytosolic tRNAs (Figures 1C and S2F) . A recent study reported m 1 A at position 9 in cytosolic tRNA Asp(GUC) ; this site is also detected by m 1 A-MAP ( Figure 1D ). Collectively, these observations suggest that m 1 A-MAP is highly sensitive in detecting m 1 A at single-base resolution. (legend continued on next page) 5 0 nucleotide than the 3 0 nucleotide; importantly, a similar sequence-dependent feature is also observed for m 1 A sites in mRNA ( Figure 2A and S3A). Therefore, we conclude that our strict threshold allowed us to confidently detect transcriptomewide m 1 A sites at single-nucleotide resolution.
Out of the 740 m 1 A modifications in the transcriptome ( Figure S3B ), 473 sites are located in mRNA and lncRNA molecules ( Figure S3C and Table S2 ). The majority of these sites are within the 5 0 UTR ( Figures 2B and 2C) , consistent with the previous finding Li et al., 2016a) . Our single-base profile also reveals multiple features of the m 1 A methylome: for instance, we found 24 m 1 A methylation sites that are present exactly at the first nucleotide of the 5 0 end of the transcripts ( Figure 2D and Table S2 ). Out of the 24 cap+1 m 1 A methylation sites, 22 are found in mRNA while the other two are located in lncRNA (Table S2) . We further validated these cap+1 m 1 A sites using an antibody-independent, locus-specific approach ( Figure S3D Figure 2G ), in agreement with a previous report 
Consensus Motif
An unbiased motif detection using DREME revealed that a subset of m 1 A (53 sites) are found within a strong GUUCRA sequence ( Figure 3A) . Interestingly, these sites demonstrate a very different distribution pattern: instead of being enriched in the 5 0 UTR, these sites are evenly distributed in the transcriptome ( Figure 3B ). Because this motif is reminiscent of the m 1 A-containing TJC loop in tRNA, we hypothesized that the tRNA methyltransferase complex TRMT6/61A could be responsible for these mRNA m 1 A sites. We first performed direct m 1 A sequencing (without antibody enrichment) on a RNA population below 200 nt to examine the substrate specificity of TRMT6/61A. We found that the m 1 A58 sites within the GUUCRA motif experienced a global decrease of mutation rate in the TRMT6/61A knockdown sample, which was not observed for m 1 A58 sites that do not conform to the motif ( Figures 3C, S4A , and S4B). This result suggests that TRMT6/61A-mediated m 1 A methylation is highly sequence specific, consistent with evidence from crystal structures (Finer-Moore et al., 2015) . We then analyzed the secondary structure for the 53 mRNA m 1 A sites and found highly conserved structural features compared to the T-loop of tRNA ( Figures S4C and S4D ). We also picked three m 1 A sites (in CDS, 3 0 UTR, and lncRNA, respectively) and examined their response after TRMT6/61A knockdown using a locus-specific approach ( Figure 3D ). This approach is based on targeted amplification using specific primers (see STAR Methods), enabling us to interrogate these sites with high sequencing depth. The results unambiguously demonstrated a decrease in the mismatch rate for these three sites after TRMT6/61A knockdown ( Figure 3D ). As a comparison, a non-motif m 1 A site located in a different structural context demonstrated an unaltered modification status ( Figure 3E ). Taken together, these observations suggest that in addition to tRNA, TRMT6/61A is also responsible for a subset of m 1 A sites in mRNA. (Suzuki et al., 2011) , catalyzed by TRMT10C and TRMT61B (Chujo and Suzuki, 2012; Vilardo et al., 2012) , respectively. m 1 A-MAP showed that all the 14 mt-tRNAs bearing an adenosine residue at position 9 are m 1 A modified; for position 58, m 1 A was detected for the three known and two additional mttRNA molecules (Figures 4A and 4B and Table S3 ). For mtrRNA, the only known m 1 A site is at position 947 of 16S rRNA (Bar-Yaacov et al., 2016) . Interestingly, we additionally detected seven and ten m 1 A sites in 16S and 12S mt-rRNA, respectively ( Figure 4 and Table S3 ). This is very different from cytosolic rRNA, where only one m 1 A site in 28S rRNA (m 1 A1322) was found. Unlike m 1 A947 in 16S mt-rRNA and m 1 A1322 in 28S rRNA (both are highly modified), the newly detected m 1 A sites are relatively low in modification level (Table S3) . We further validated the presence of m 1 A in 12S mt-rRNA by both quantitative MS and a primer extension assay ( Figures 4C, S5A , and S5B).
In human mitochondria, mRNAs are transcribed from the heavy and light strands as polycistronic units (Falkenberg et al., 2007; Mercer et al., 2011) . The processed mt-mRNAs See also Figure S3 . See also Figure S4 .
. 378 (legend continued on next page) lack a cap at the 5 0 end and contain no or short untranslated regions (Richter-Dennerlein et al., 2015; Rorbach and Minczuk, 2012; Temperley et al., 2010) . We identified 22 m 1 A sites from 10 of 13 mitochondrial genes, in which 21 are residing in CDS and one is located in the 3 0 UTR ( Figures 4A and 4B ). This is distinct to the m 1 A methylome in the nuclear-encoded transcripts, where m 1 A is enriched in the 5 0 UTR. In addition, no preference for codon types was observed, yet m 1 A appears to be more likely present at the third position of a codon in the CDS of mt-mRNA ( Figure S5C ). By analyzing the published CLASH (cross-linking, ligation and sequencing of hybrids) results in which microRNA and their direct mRNA targets are captured (Helwak et al., 2013) , we found two m 1 A sites that are located within the experimentally verified targets of microRNA ( Figure S5D ). In fact, these m 1 A sites reside exactly within mRNA sequences that form base-pairing with the seed regions of microRNAs. More m 1 A sites in mt-mRNA were found within the predicted mt-mRNA targets of the microRNA seed regions ( Figure S5D ). Lastly, we also identified 25 m 1 A sites within the in- (Table S3) , we also surveyed publicly available RNA-seq data for the presence of m 1 A at this position (Kondo et al., 2017; Li et al., 2015 Li et al., , 2016a Quiró s et al., 2017) . Although the RT conditions differ greatly among the datasets, we were able to consistently find a mutation rate of $2%-9% for this position ( Figure 4E ). Interestingly, the modification level of m 1 A1374 appears to be dynamically regulated by different stress conditions ( Figure 4E ). For instance, its modification level is upregulated under heat shock and hypoxia conditions, while it is downregulated upon serum starvation and treatment with actinonin, a drug that alters mitochondrial proteostasis. Hence, similar to the nuclear genome-encoded mRNA m 1 A methylome Li et al., 2016a) 
MT-CO1, MT-CO2, MT-CO3, MT-CYB, and
MT-ND4L) out of the ten m 1 A-modified mt-mRNAs were targeted by TRMT61B ( Figure 5B and Table S4 ). This observation suggests that in addition to mt-tRNA and mt-rRNA, TRMT61B could also modify mt-mRNA. Because of the high efficiency of TRMT61B overexpression in increasing the m 1 A level, we used mass spectrometry to quantitatively measure the mitochondrial protein level upon TRMT61B overexpression ( Figure S5I ). Indeed, TRMT61B overexpression led to a reduced protein level for MT-CO2 and MT-CO3 ( Figures 5C and S5J ), which are components of Complex IV; importantly, for MT-ATP6 and MT-ATP8 that are not targeted by TRMT61B, their protein levels remain unaffected. We also used metabolic labeling to further demonstrate that TRMT61B overexpression-induced translation repression is specific to mt-mRNA targets of TRMT61B, but not to non-targets of TRMT61B ( Figure 5D ). We further confirmed this observation using western blot for MT-CO2 and MT-ATP6, a target and non-target of TRMT61B, respectively ( Figure 5E ). Of note, upon TRMT61B knockdown, the protein productions for several non-targets of TRMT61B were reduced ( Figure S5K ), presumably due to the decreased modification level in tRNA and rRNA m 1 A sites (which are originally highly modified and beneficial (B) m 1 A methylome of the light strand.
(C) Detection of two novel m 1 A sites at position 378 and 575 in 12S mt-rRNA using a primer extension assay. In the immunoprecipitated samples (denoted as ''IP''), the m 1 A modification at the two sites can be unambiguously detected. In the mock control samples (without immunoprecipitation), the bands corresponding to m 1 A378-and m 1 A575-induced reverse transcription (RT) arrest were weak, indicating a relatively low stoichiometry of these sites. Upon TRMT61B overexpression, strong bands were observed, suggesting that these two sites can be targeted by TRMT61B. sequences strongly suggest that such an estimation should be done with caution: TGIRT underestimates m 1 A modification level, and m 1 A-induced mismatch decreases in a non-linear fashion as the modification level decreases. Additionally, the sequence context of RNA has also been reported to affect the mutation rate (Hauenschild et al., 2015; Zubradt et al., 2017) . Hence, while direct sequencing (without enrichment) could still detect m 1 A sites with high modification levels, m 1 A sites with average modification levels or those located within a non-optimal context for mismatch induction could be missed. Therefore, coupling the pre-enrichment step to the mutational signature is necessary to improve detection sensitivity. In addition, to achieve high confidence, we employed an in vitro demethylation step, which enabled us to distinguish true m 1 A sites from false signals (SNP, other modifications, etc.) in the transcriptome. The combined use of mutational signature, the pre-enrichment step, and the in vitro demethylation step enabled m 1 A-MAP to achieve high sensitivity and confidence. Of note, AlkB also demethylates several other methylations in RNA (e.g., m 3 C and m 1 G) (Cozen et al., 2015; Zheng et al., 2015) ; hence, with the help of specific antibodies for these methylations, our strategy could in principle be applied to these modifications as well. Our study revealed that two known m 1 A modification machineries, TRMT6/61A and TRMT61B, could work on mRNA as well.
The hetero complex TRMT6/61A recognizes the sequence and structure of the tRNA T-loop and installs an m 1 A at the 58 position (Finer-Moore et al., 2015) . Consistent with this knowledge, we found that the TRMT6/61A-dependent mRNA m 1 A sites are also confined to a hairpin structure mostly with a 7-nt loop, reminiscent of the tRNA T-loop. In contrast, we did not find an obvious sequence context for the m 1 A in mt-mRNA. In fact, TRMT61B appears to be a promiscuous enzyme that also modifies mt-tRNA and mt-rRNA; the substrate specificity and the underlying mechanism of TRMT61B in the human mitochondria remains to be determined. In addition, the fact that both TRMT6/61A and TRMT61B are known tRNA modification enzymes also reminds us of the modification machinery for other mRNA modifications. For instance, eukaryotic J synthases PUS1, PUS7, and TRUB1 can work on both tRNA and mRNA (Carlile et al., 2014; Li et al., 2015; Lovejoy et al., 2014; Safra et al., 2017; Schwartz et al., 2014a ), yet the modification complex for m 6 A, consisting of at least METTL3, METTL14, WTAP, and KIAA1429, appears to be dedicated to mRNA (Bokar et al., 1997; Liu et al., 2014; Ping et al., 2014; Schwartz et al., 2014b) . In the case of m 1 A, the enzyme(s) responsible for the majority of the modification sites in mRNA remain to be identified. It would be interesting to see if such machinery is specific for mRNA or promiscuous for multiple RNA substrates. Our results also revealed prevalent m 1 A methylation in mtmRNA; this is due to the utilization of a stranded library preparation strategy in this study as compared to the previous methods Li et al., 2016a ). Similar stranded library preparation strategy has also enabled the identification of pseudouridylation in mt-mRNA (Antonicka et al., 2017 A level in mRNA than in these ncRNAs. In this simplified scenario, we indeed observed greatly increased modification levels for several mt-mRNAs upon TRMT61B overexpression and detected reduced protein levels for such mt-mRNA transcripts. Importantly, protein levels for non-targets of TRMT61B, which are either devoid of m 1 A or contain TRMT61B-independent m 1 A sites, remain unaffected upon TRMT61B overexpression. Hence, TRMT61B overexpression-mediated translation repression is caused by mt-mRNA m 1 A and is specific to its mt-mRNA targets. For the mt-mRNAs that contain TRMT61B-independent m 1 A sites, additional meth- could interfere with base pairing to microRNA, which is thought to enhance translation in mitochondria . While both the speculated mechanisms point to a suppressive role of m 1 A in mitochondria translation, alternative hypotheses and mechanisms should also be tested in future experiments. Nevertheless, our discovery that m 1 A in mt-mRNA interferes with translation improves our understanding of translation regulation in human mitochondria.
In summary, our study demonstrated distinct classes of m 1 A methylome in the nuclear-and mitochondrial-encoded transcripts. Our single-nucleotide-resolution m 1 A technology allowed the comprehensive profiling of m 1 A in the human transcriptome, providing a reference and resource for future investigations to elucidate the biological functions and mechanisms of this epitranscriptomic mark.
Limitations
Our current procedure of m 1 A-MAP favors sensitivity and accuracy over the quantitative ability, due to the involvement of a preenrichment step using an m 1 A antibody. For the m 1 A sites located in abundant RNAs (rRNA, tRNA, and a limited subset of mRNA), their modification levels could be estimated by comparing the mismatch rates in the Input sample with a stoichiometry curve (similar to Figure S2C ). However, for the majority of mRNA molecules in the transcriptome, only limited sequencing reads could be obtained by transcriptome-wide sequencing experiments. Thus, stoichiometry for m 1 A sites in less abundant mRNA molecules may not be reliably estimated by their mismatch rates in the Input sample. To address this limitation, the modification level of m 1 A-MAP-identified m 1 A sites can be estimated via additional locus-specific sequencing to the Input samples, which would allow sufficient sequencing depth while remaining cost effective. The exact stoichiometry of these sites can then be determined by fitting the mismatch rates in the locus-specific sequencing into the stoichiometry curve of synthetic spike-in RNAs that contain the exact sequence of the RNA molecules of interest.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
HEK293T was maintained at 37 C in DMEM medium (GIBCO) supplemented with 10% FBS (GIBCO) and 1% penicillin/streptomycin (GIBCO).
METHOD DETAILS
Cell Culture and Antibodies HEK293T (ATCC, CRL-11268) was used in this study and maintained in DMEM medium (GIBCO) supplemented with 10% FBS (GIBCO) and 1% penicillin/streptomycin (GIBCO). Monoclonal mouse anti-m 1 A antibody was purchased from MBL (D345-3). Polyclonal rabbit anti-TRMT6 antibody was purchased from Santa Cruz Biotechnology (sc-271752). MT-CO2 antibody (55070-1-AP) and MT-ATP6 antibody (55313-1-AP) was purchased from Proteintech Group. Monoclonal mouse anti-b-Actin antibody was purchased from CWBiotech (CW0096). Monoclonal mouse anti-GAPDH antibody was purchased from CWBiotech (CW0100M).The secondary antibodies used were anti-mouse-IgG-HRP (CW0102; CWBiotech) and anti-rabbit-IgG-HRP (CW0103; CWBiotech).
RNA isolation
Total RNA was isolated from cells using TRIzol, according to the manufacturer's instructions (Invitrogen). An additional DNase I treatment step was performed to avoid DNA contamination. For polyA + RNA isolation, small RNA was first depleted using MEGAclear Transcription Clean-Up Kit (Ambion), followed by two successive rounds of polyA + selection using oligo(dT) 25 Dynabeads (Invitrogen). For small RNA isolation, RNA smaller than 200 nt was recovered from the flow-through fraction in the small RNA depletion step by ethanol precipitation.
shRNA knockdown of TRMT6/61A The oligoes targeting TRMT6 and TRMT61A were annealed and cloned into the pLKO vector according to the TRC shRNA library protocol (https://www.broadinstitute.org/rnai/public/), respectively. The oligo sequences were listed below:
TRMT6-FWD: CCGGGGGAAAGTTCTGAGTATTTATCTCGAGATAAATACTCAGAACTTTCCCTTTTTG TRMT6-RVS: AATTCAAAAAGGGAAAGTTCTGAGTATTTATCTCGAGATAAATACTCAGAACTTTCCC TRMT61A-FWD: CCGGGAGGCCAGAGGCACCTTATATCTCGAGATATAAGGTGCCTCTGGCCTCTTTTTG TRMT61A-RVS: AATTCAAAAAGAGGCCAGAGGCACCTTATATCTCGAGATATAAGGTGCCTCTGGCCTC A scrambled shRNA was used as the mock control. Lentiviruses were packaged by co-transfecting HEK293T cells with pLKO-TRMT6, pLKO-TRMT61A, pCMV-dR8.91 and VSV-G plasmids, following the instructions from Broad Institute. The supernatant from transfected cells was harvested after 2 days and used to infect HEK293T cells followed by puromycin selection for 5 days. Knockdown efficiency was verified by western blot and qPCR. qPCR primers were listed as follows: TRMT6-qFWD: CTGTCTTTGCTGGACTTTGTGGC; TRMT6-qRVS: AGACAGCCTGAGGTTGATGACC; TRMT61A-qFWD: TCCTCTACTCCACAGACATCGC; TRMT61A-qRVS: CAATG GTGCGGATGATGGCGTG. C for 6 h, followed by the addition of 2.5 mL 0.5 M MES buffer, pH 6.5 and 0.5 U alkaline phosphatase (Sigma, P4252). The mixture was incubated at 37 C for another 6 h and diluted to 50 mL. 5 mL of the solution was injected into LC-MS/MS. The nucleosides were separated by ultra-performance liquid chromatography with a C18 column, and then A contamination in the m 1 A oligoes, which was introduced during the oligo purification process, was measured using quantitative LC-MS/MS. The m 1 A-oligo was mixed with the A-oligo to ratios: 100%, 75%, 50%, 25%, 12.5%, 6.25% and 0%, respectively. The mixed m 1 A/A oligoes were subjected to library construction using specific RT primers as listed below:
Cloning, Expression and Purification of AlkB A truncated AlkB with deletion of the N-terminal 11 amino acids was cloned into pET30a (Novagen) and transformed to E. coli BL21(DE3) followed by culturing in LB medium at 37 C until the OD 600 reached 0.6-0.8, and further incubating at 30 C for additional 4 h with the addition of 1 mM IPTG. Proteins were purified using Ni-NTA chromatography (GE Healthcare) and gel-filtration chromatography (Superdex 200, GE Healthcare) followed by Mono-Q anion exchange chromatography (GE Healthcare). Such purification procedure effectively avoided RNA contamination from E. coli (the expression host).
In vitro Demethylation treatment
We employed two different strategies for the removal of methyl-group at the N1 position of adenosine.
In vitro demethylation mediated by the purified AlkB protein: 10 mg full-length polyA + RNA was fragmented at 94 C for 5 min using magnesium RNA fragmentation buffer (NEB) and fragmented polyA + RNA was desalted and concentrated by ethanol precipitation.
10 mg ($0.2 nmol) fragmented polyA + RNA was denatured at 65 C for 5 min, and then subjected to demethylation reaction in a 500 mL demethylation mixture containing 0.4 nmol purified AlkB, 50 mM MES, pH 6.5, 283 mM of (NH 4 ) 2 Fe(SO 4 ) 2 $6H 2 O, 300 mM 2-ketoglutarate, 2 mM L-ascorbic acid, 1 U/mL SUPERaseIn RNase Inhibitor (Invitrogen). The demethylation reaction was incubated at 37 C for 2 h and quenched by adding 5 mM EDTA. The demethylated RNA was then purified by phenol chloroform extraction.
In vitro demethylation mediated by the Dimroth rearrangement: 10 mg full-length polyA + RNA was incubated in alkaline buffer (0.1 M Na 2 CO 3 /NaHCO 3, 5mM EDTA, pH 10.2) at 65 C for 3 h, and then the treated RNA was purified by ethanol precipitation.
A-MAP 40 mg polyA + RNA was fragmented to $150 nt using magnesium RNA fragmentation buffer (NEB). m 1 A-containing RNA fragments were enriched through m 1 A immunoprecipitation as previous described (Li et al., 2016a) . 10 ng ($0.2 pmol) of the immunoprecipitated m 1 A-containing RNA fragments were subjected to the AlkB demethylation treatment. Demethylation reaction was performed in a 20 mL demethylation mixture containing 0.4 pmol purified AlkB, 50 mM MES, pH 6.5, 283 mM of (NH 4 ) 2 Fe(SO 4 ) 2 $6H 2 O, 300 mM 2-ketoglutarate, 2 mM L-ascorbic acid and 0.4 U/mL RNase inhibitor, following with an incubation at 37 C for 2 h. The reaction was quenched by the addition of 5 mM EDTA, and the demethylated RNA was purified by phenol chloroform extraction followed with ethanol precipitation.
Fragmented polyA + RNA (as ''Input''), immunoprecipitated RNA [as ''(-) demethylase''] and demethylated immunoprecipitated RNA [as ''(+) demethylase''] were subjected to library construction. The library construction was performed according to the eCLIP library construction protocol with several modifications (Van Nostrand et al., 2016) . For dephosphorylation of 3 0 ends, RNA samples were treated by PNK (NEB) with an incubation at 37 C for 1 h, and followed by a heat-inactivation of PNK at 65 C for 20 min. The dephosphorylated RNA was purified by ethanol precipitation and then subjected to 3 0 RNA linker ligation using T4 RNA ligase2, truncated KQ (NEB) at 25 C for 2 h. The 3 0 RNA linker sequence is: 5 0 rAPP-AGATCGGAAGAGCGTCGTG-3SpC3. The excess RNA adaptor was digested by adding 1 mL 5 0 Deadenylase (NEB) into the ligation mix followed by an incubation at 30 C for 1 h, and then adding 1 mL RecJf (NEB), incubating at 37 C for another 1 h. The enzymes were then heat-inactivated at 70 C for 20 min, and the RNA was purified by ethanol precipitation. The RNA pellet was dissolved in 10 mL H 2 O and then 1 mL 2 mM RT primer (ACACGACGCTCTTCCGATCT) was added. RNA-primer mix was denatured at 80 C for 2 min and then chilled on ice immediately. RT reaction buffer (50 mM Tri-HCl pH 8.3, 75 mM KCl, and 3 mM MgCl 2 , final), dNTPs (1 mM, final), DTT(5 mM, final), RNase Inhibitor (1 U/mL, final) and 1 mL TGIRT (InGex) were added into the denatured RNA-primer mix and reverse transcription was carried out at 57 C for 2 h. Excess RT primer was digested by the addition of 1 mL Exonuclease I (NEB) and a following incubation at 37 C for 30 min. cDNA was purified using silane beads (Invitrogen) and then ligated to the 5 0 adaptor (5Phos-NNNNNNNNNNAGATCGGAAGAGCA CACGTCTG-3SpC3). Ligation was performed with T4 RNA ligase 1, high concentration (NEB) at 25 C overnight. The ligated cDNA was purified using silane beads, and then subjected to PCR amplification with the following primers: 5 0 -AATGATACGGCGACCACC GAGATCTACACTCTTTCCCTACACGAC GCTCTTCCGATCT-3 0 , 5 0 -CAAGCAGAAGACGGCATACGAGATXXXXXXGTGACTGGAGT TCAGACGTGTGCTCTTCCGATC-3 0 (XXXXXX represents index sequence). PCR product was purified by 8% TBE gel. The libraries were sequenced on Illumina Hiseq X10 with paired-end 2 3 150 bp read length. 
Locus

A486-RVS: AGCCGGGGTCTCTGTGG
Purification of Mitochondrial 12S mt-rRNA Total RNA was isolated from cells using TRIzol, according to the manufacturer's instructions (Invitrogen). An additional DNase I treatment step was performed to avoid DNA contamination. Bring 200 mg DNase I treated total RNA to volume of 160 mL in nuclease-free water, and then add 1 mL 12S mt-rRNA probe mix (20 mM each). The probe mix contains 4 3 0 -biotin labeled oligoes that specifically target 12S mt-rRNA and the sequences were listed as follows: 12S-probe-1: GAGCTAATAGAAAGGCTAGGAC; 12S-probe-2: TCTATTGACTTGGGTTAATC; 12S-probe-3: TTATCGATTACAGAACAGGCT; 12S-probe-4: TCTACTCTTAGTTTACTGCTAA. The RNA mixture was heated at 65 C for 10 min and followed by chilling on the ice. 40 mL 5 3 Binding buffer (1.5 M NaCl, 10 mM EDTA, 100 mM Tris, pH 7.4) was added into the RNA mixture and mixed well by pipetting. The RNA mixture was incubated at room temperature for about 30 min. 200 mL Streptavidin C1 Dynabeads (Invitrogen) was resuspended in 200 mL Binding Buffer (300 mM NaCl, 2 mM EDTA, 20 mM Tris, pH 7.4) and then added into the RNA mixture. The RNA beads mixture was incubated at room temperature for 40 min by gently rotating. The beads was washed with Washing Buffer (30 mM NaCl, 1 mM EDTA, 10 mM Tris, pH 7.4, 1% SDS) at 40 C for four times. RNA was eluted from beads by adding 200 mL Elution buffer (5 mM EDTA, 10 mM Tris, pH 7.4, 1% SDS) and incubating at 70 C for 10 min. Isolated RNA was recovered by ethanol precipitation and 12S mt-rRNA was further selected using 4% Urea-PAGE. The purity of isolated 12S mt-rRNA was checked using RNA 6000 Pico Chip on an Agilent 2100 Bioanalyzer (Agilent Technologies). The m 1 A methylation level of 12S mt-rRNA was analyzed by quantitative LC-MS/MS.
Primer extension
The primer extension was performed as previously reported (Bar-Yaacov et al., 2016; Chujo and Suzuki, 2012) with several modifications.
To detect m 1 A1374 in MT-ND5, 2 mg mRNA was mixed with 10 fmol 5 0 biotin labeled primer (ND5-m 1 A1374-primer: CCTGCGAA TAGGCTTCC) in a 5 mL solution containing 10 mM Tris, pH 7.5 and 1 mM EDTA. The RNA mixture was then heated at 80 C for 2 min and slowly cooled to 25 C over 55 min. The RT mixture (containing 2 mL 5 3 First-Strand Buffer, 1.5 mL 25 mM MgCl 2 , 0.5 mL 0.1 M DTT, 0.5 mL Superscript III, 0.25 mL RNase inhibitor, 0.25 mL 1.5 mM ddATP, dTTP, dCTP, and dGTP mix) was then added into the RNA mixture and mixed well. The reverse transcription was carried out at 55 C for 1 h and then the RNA template was digested with RNase H. The reverse transcribed products were separated by 20% Urea-PAGE and then transferred to Nylon membrane, detected by chemiluminescent nucleic acid detection module (Thermo, 89880).
To detect m 1 A378 and m 1 A575 in 12S mt-rRNA, 50 ng fragmented total RNA or 20 ng immunoprecipitated RNA was mixed with 5 fmol 5 0 biotin labeled primer (12S-m 1 A378-primer: TGTGTTCAGATATGTTAAAG; 12S-m 1 A575-primer: GAGGTGGTGAGGTT GATCG) and then subjected to reverse transcription as described above. The d/ddNTP mix consisted of dATP, dTTP, dCTP and ddGTP for m 1 A378 in 12S mt-rRNA; ddATP, dTTP, dCTP and dGTP for m 1 A575 in 12S mt-rRNA. The reverse transcription was carried out at 49 C for 12S-m 1 A378 and 55 C for 12S-m 1 A575. The reverse transcribed products were analyzed as described above.
siRNA Knockdown and overexpression of TRMT61B Two synthesized duplex RNAi oligoes targeting TRMT61B mRNA sequences were used: 5 0 -GGAUAUCAACCCAGGUGAUTT-3 0 and 5 0 -GCGUGAUUCAUGGAAAUUATT-3 0 ; a scrambled duplex RNAi oligo (5 0 -UCCUCCGAACGUGUCACGUTT) was used as the mock control. The siRNA oligo was transfected into HEK293T by Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's instructions, and cells were harvested 48 h later after transfection. Knockdown efficiency was examined by qPCR. qPCR primers were listed as follows: TRMT61B-qFWD: CAGGAGCAACCGAAGACAT; TRMT61B-qRVS:ATATACAGCACATACACCACCAT;
For the construction of overexpression plasmid, TRMT61B was cloned into pcDNA3.1 using the following primers: FWD: TCGCGAAACACTATGCTAATGGC; RVS: GTTAAGTTGTGGTTTGACCTTCCTC. The empty pcDNA3.1 vector was used as the mock control. The plasmid was transfected into HEK293T by Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions and cells were harvested 48 h later after transfection.
Ribosome profiling 2 plates of 15-cm HEK293T cells were grown to 90% confluency; CHX was then added to the medium at a final concentration of 100 mg/mL. Cells were treated in the CHX-medium for 7 min before they were harvested and lysed with 1 mL lysis buffer (10 mM Tris-HCl, pH 7.4, 5 mM MgCl 2 , 100 mM KCl, 1% Triton X-100, 2 mM DTT, 100 mg/mL CHX, 0.5 U/mL RNase inhibitor, 1 3 complete protease inhibitor). The cell lysates were centrifuged at 15,000 g for 15 min, and the supernatant was collected and sent for the OD260 measuring. 100 mL lysates were kept as input sample and 1 mL TRIzol was added to purify the RNA. 1 mL Micrococcal Nuclease (NEB) per 25OD was added to the remaining cell lysates and incubated at 25 C for 20 min. The digested cell lysates were used for performing ribosome foot-printing. The lysates were fractioned on 10/50% w/v sucrose gradients using the SW-40Ti rotor at 27,500rpm for 4h. 80S monosome fraction was collected, followed by the addition of equal volume of extraction buffer (1% SDS, 40 mM EDTA). RNA was isolated by phenol-chloroform extraction. RNA fragments between 28-30 nt were selected using 15% Urea-PAGE. Recovered RNA fragments were subjected to library construction. In brief, RNA samples were dephosphorylated with PNK (NEB) and ligated to 3 0 RP linker (5 0 rAPP-CTGTAGGCACCATCAAT-3SpC3) using T4 RNA ligase2, truncated KQ (NEB). Reverse transcription was carried out using Superscript III (Invitrogen) with RP-RT primer (5Phos-AGATCGGAAGAGCGTCG TGTAGGGAAAGAGTGTAGATCTCGGTGGTCGC-SpC18-CACTCA-SpC18-TTCAGACGTGTGCTCTTCCGATCTATTGATGGTGCC TACAG). cDNA was circ-ligated with CircLigase II (Epicenter) and then amplified by PCR with primers (5 0 -AATGATACGG CGACCACCGAGATCTACAC-3 0 ; 5 0 -CAAGCAGAAGACGGCATACGAGATXXXXXXGTGACTGGAGTTCAGACGTGTGCTCTTCCGA TC-3 0 , XXXXXX represents index sequence). PCR products were purified by 8% TBE gel and sequenced on Illumina Hiseq 2500 with single end reads (50 bp).
qPCR-based m 1
A level evaluation 20 mg polyA + RNA was isolated from HEK293T cells with TRMT61B overexpression, knockdown and the corresponding mock controls, respectively. RNA was fragmented into $150 nt using magnesium RNA fragmentation buffer (NEB) and concentrated by ethanol precipitation. Fragmented RNA (as Input) was denatured and incubated with 2 mg anti-m 1 A antibody in IPP buffer (150 mM NaCl, 0.1% NP-40, 10 mM Tris, pH 7.4) at 4 C overnight. 20 mL Protein A/G UltraLink Resin (Pierce) was added to the RNA-antibody mixture and incubated at 4 C for additional 3 h. Resins were washed for twice with IPP buffer, once with low salt buffer (75 mM NaCl, 0.1% NP-40, 10 mM Tris, pH 7.4), once with high salt buffer (200 mM NaCl, 0.1% NP-40, 10 mM Tris, pH 7.4) and twice with TEN buffer (10 mM Tris, pH 7.4, 1 mM EDTA, pH 8.0, 0.05% NP-40). m 1 A-containing RNA was eluted from resins with 3 mg/mL N 1 -methyladenosine (Berry&Associates) in IPP buffer and purified by phenol chloroform extraction and ethanol precipitation. Input and immunoprecipitated samples were reverse transcribed into cDNA using Superscript III (Invitrogen) and quantified by qPCR using SYBR GREEN mix (Takara) on Roche Lightcycler 96 real-time PCR system. The m 1 A-IP/Input ratios of the targeted regions were calculated for the TRMT61B overexpression, knockdown and the corresponding control samples, respectively. The primers used for qPCR were listed below:
MT-CO1-qFWD: CCTATCATCTGTAGGCTCATTC MT-CO1-qRVS: GGAGGGTTCTTCTACTATTAGGAC MT-CO2-qFWD: ACAGATGCAATTCCCGGACG MT-CO2-qRVS: CCACAGATTTCAGAGCATTGACC MT-CO3-qFWD: CGCCTGATACTGGCATTTTG MT-CO3-qRVS: GACCCTCATCAATAGATGGAGAC MT-CYB-qFWD: CAACCCCCTAGGAATCACCTC MT-CYB-qRVS: GAGGGCGTCTTTGATTGTGTAG 16S rRNA-qFWD: ATGAATGGCTCCACGAGGG 16S rRNA-qRVS: CTTGCTGTGTTATGCCCGC Reductive dimethylation labeling Mitochondrion was isolated from TRMT61B overexpression and mock control HEK293T cells according to the manufacturer's (Thermo Fisher) and lysed with RIPA buffer followed by sonication. The extracted proteins from different samples were quantified with the BCA protein assay kit (Thermo Fisher). Equal amount of proteins from two samples were digested by trypsin on-column in 100 mM TEAB buffer and subjected to reductive dimethylation labeling. 4 mL of 4% (w/w) light or heavy formaldehyde was added to 100 mL of trypsin digested samples prepared from TRMT61B overexpression and mock control HEK293T cells, respectively. In the meantime, 4 mL of 0.6 M sodium cyanoborohydride was added and the samples were incubated at room temperature for 1h. The dimethylation labeling reaction was quenched by the addition of 1% (w/w) ammonia and 5% (w/w) formic acid. Finally, light and heavy labeled peptide samples were mixed, concentrated by vacuum, and analyzed on a Q Exactive mass spectrometer (Thermo Fisher).
LC-MS/MS and data analysis
The peptides were analyzed on a Q Exactive mass spectrometer (Thermo Fisher). Under the positive-ion mode, full-scan mass spectra was acquired over the m/z range from 350 to 1800 using the Orbitrap mass analyzer with mass resolution setting of 70000. MS/MS fragmentation was performed in a data-dependent mode, of which the 20 most intense ions were selected from each full-scan mass spectrum for high-energy collision induced dissociation (HCD) and MS2 analysis. MS2 spectra were acquired with a resolution setting of 17500 using the Orbitrap analyzer. Some other parameters in the centroid format: isolation window, 2.0 m/z units; default charge, 2+; normalized collision energy, 28%; maximum IT, 50 ms; dynamic exclusion, 20.0 s. LC-MS/MS data were analyzed by ProLuCID (Xu et al., 2015) with static modification of cysteine (+57.0215 Da) and variable oxidation of methionine (+15.9949 Da). The searching results were filtered by DTASelect (Tabb et al., 2002) and peptides were also restricted to fully tryptic with a defined peptide false positive rate of 1%. The ratios of reductive dimethylation were quantified by the CIMAGE software as described before (Weerapana et al., 2010) .
Pre-processing of raw sequencing data A random barcode of 10 nt was included in the adaptor that ligates to the 3 0 end of cDNA and it cannot be precisely located in Read 1. Hence, only Read 2 data of m 1 A-MAP was used for subsequent analyses. Raw sequencing reads produced from m 1 A-MAP were first subjected to Trim_galore (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) for quality control and adaptor trimming. The minimum quality threshold was set to 20, and the minimum length required for reads after trimming was 30 nt. The remaining reads were further processed by removing the first 10 nt random barcode in the 5 0 end. As for the ribosome profiling (Ribo-seq) data and the corresponding RNA-seq data, reads with a quality lower than 20 were discarded, and the adaptor in 3 0 end was trimmed. Processed reads with a length ranging from 25 nt to 35 nt in the ribosome profiling sample were kept for further analysis.
Reads mapping and PCR duplication removing Processed reads were mapped to human transcriptome or mitochondrial genome using BWA-MEM with default parameters (version 0.7.15-r1140) ). Reference transcriptome was prepared based on the Refseq annotation of human (hg19) downloaded from the table browser of UCSC database. The redundant sequences with the same Refseq id were removed. Transfer RNA (tRNA) sequences were also downloaded from UCSC table browser and integrated into the transcriptome. Mitochondrial genome and corresponding annotation were downloaded from NCBI (NC_012920.1). Reads mapping to an identical position of reference were considered as PCR duplications if their 10 nt random barcodes were the same, and only one of these reads was kept. Performances related to the processing of sam/bam file were done with the help of SAMtools ) (http://samtools.sourceforge. net/).
Identification of m 1
A sites Mismatch rate of each nucleotide in the reference sequences was calculated for both (-) and (+) demethylase samples. Two parameters were defined to evaluate the dynamic change of mismatch rate in the (-) demethylase and (+) demethylase samples: difference of mismatch rate (Diff) and fold change of mismatch rate (FC). Diff was calculated by subtracting the mismatch rate in the (+) demethylase from that in the (-) demethylase sample, while FC was calculated by dividing the mismatch rate in the (-) demethylase by that in the (+) demethylase sample. FC was artificially set to ''1000'' if the mismatch rate in the (+) demethylase sample was ''0.'' A position was identified as an m 1 A site when the following criteria were met: a) FC > = 3; b) Diff > = 10%; c) the number of reads with a mismatch at the position was no less than 5; d) criteria (a-c) were all fulfilled in both replicates.
In order to evaluate the frequency of potential false positives caused by m 1 A-independent mismatch, we employed a reverse calling procedure. Specifically, the ''reverse calculation'' of Diff and FC values for each position were performed following the equations below:
Diff opposite = ð + Þdemethylase À ðÞdemethylase; FC opposite = ð + Þdemethylase=ðÞdemethylase:
Under such circumstance, only 17 sites passed the above-mentioned threshold, suggesting the m 1 A-independent mismatch should minimally interfere with the identification of true m 1 A sites.
Identification of TRMT61B targets in mitochondrial-encoded transcripts For the identification of TRMT61B targeting sites in mitochondrial-encoded RNA, the mismatch rate in the Input sample was first calculated for mock control sample and TRMT61B overexpression sample, respectively. Two parameters were defined to evaluate the increase of mismatch rate from the mock to TRMT61B o/e sample: difference of mismatch rate (Diff) and fold change of mismatch rate (FC). Diff was calculated by subtracting the mismatch rate in the mock sample from that in the TRMT61B o/e sample, while FC was calculated by dividing the mismatch rate in the TRMT61B o/e by that in the mock sample. FC was artificially set to ''1000'' if the mismatch rate in the mock sample was ''0.'' A position was identified as TRMT61B target when the following criteria were met: a) FC > = 5; b) Diff > = 5%; c) the site was covered by more than 500 sequencing reads; d) criteria (a-c) were all fulfilled in both replicates.
Motif discovery and GO enrichment analysis
For the analysis of sequence consensus, 15 nt of sequence neighboring each m 1 A site was retrieved. These sequences were then subjected to DREME algorithm in MEME suite (Version 4.12.0) for the discovery of enriched motifs (Bailey et al., 2009 ). The shuffled input sequences were used as the background to eliminate potential false positives caused by the nucleotide composition.
Gene Ontology (GO) enrichment analyses were performed using DAVID web-based tool (https://david.ncifcrf.gov) (Huang et al., 2009 ).
Secondary structure and minimum free energy analysis 12 nucleotides of the 5 0 end and 10 nucleotides of the 3 0 end of each m 1 A site (hence 23 nt sequence in total) were retrieved for local structure analysis. RNAfold (v2.3.4) (http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi) was used to predict the secondary structure and calculate the corresponding minimum free energy (MFE). The length of the loop where m 1 A resides was determined based on the predicted structure; for an m 1 A site that is not located in a loop, this value was set to ''0.'' The significance test of MFE between m 1 A sites within the GUUCRA motif and other m 1 A sites was performed using Mann-Whitney U-test.
Ribosome profiling data analysis and TE calculation Ribo-seq and corresponding RNA-seq reads were aligned to the transcriptome, and RPKM (Reads Per Kilobase per Million mapped reads) of each transcript was calculated. Translation efficiency (TE) was defined for each transcript as the ratio of the RPKM in Riboseq to the RPKM in RNA-seq. For the analysis of influence of m 1 A on mitochondrial gene translation, mitochondrial ribosome profiling data were downloaded from the GEO Datasets (GSE48933) (Rooijers et al., 2013) . The depth of reads covered for each nucleotide along the mitochondrial transcripts was retrieved using Samtools depth tool.
miRNA target analysis
The predicted miRNA targeting sites on mitochondrial coding genes were downloaded from the miRWalk database (v2.0) (Dweep and Gretz, 2015) , which depends on the base-paring between ''seed region'' and gene sequence. The minimum length required for the match of seed region was set to 7 nt. The experimentally identified miRNA targeting sites were retrieved from the published CLASH results (Helwak et al., 2013) .
Detection of mitochondrial nascent protein synthesis
The TRMT61B knockdown cells and mock control cells were washed with pre-warmed methionine-free medium and incubated in methionine-free medium for 45 min. Then Cells were treated with 50 mg/mL emetine in methionine-free medium for 15 min to inhibit cytoplasmic protein synthesis. Further the medium was replaced with methionine-free medium containing 1 mM methionine analog L-azidohomoalanine (AHA) (Click Chemistry Tools) and 50 mg/mL emetine. After incubation for 1 h, cells were harvested using clod PBS. Total proteins from different cell lines were quantified with the BCA protein assay kit (Thermo Fisher). Equal amount of AHAcontaining proteins were labeled with Cy3 (Click Chemistry Tool) via Click Chemistry. The click reaction was performed in RIPA buffer containing 550 mM Cy3-alkyne, 4 mM BTTAA-CuSO4 complex and 151.43 mM sodium ascorbate. The reaction was incubated for 2 h at 25 C with gentle vortex. The labeled proteins were purified by chloroform/methanol precipitation and separated in a 8%-16% gradient SDS-PAGE, and the SDS-PAGE gel was visualized by Typhoon 9500 scan. The gel was also subjected to Coomassie blue staining as loading control.
Enrichment of nascent protein
The TRMT61B overexpression cell lines and mock control cell lines were washed with pre-warmed methionine-free medium and starved of methionine in the methionine-free medium for 1 h. Then the medium was replaced with methionine-free medium containing 1 mM L-azidohomoalanine (AHA). After incubation for 2 h, the cells were harvested using cold PBS. Equal amount of AHA-containing proteins were labeled by biotin-alkyne (Click Chemistry Tool) via click reaction. The purified proteins were incubated with 200 mL Streptavidin Agarose Resin (Thermo) in RIPA buffer for 3 h at 29 C. Resins were washed 3 times with PBS and 3 additional times with water. Proteins were reduced by incubated at 37 C in the presence of 10mM DTT in 6M Urea in PBS for 30min and later alkylated by adding iodoacetamide (Sigma) to the final concentration of 20 mM for another 30min. Resins were sequentially washed once with PBS and once with 100nM Triethylammonium bicarbonate (TEAB) buffer. Proteins were digested ''on bead'' with trypsin in 100 mM TEAB and 1 mM CaCl 2 buffer overnight at 37 C. The peptide solution was performed reductive dimethylation labeling and analyzed on a Q Exactive mass spectrometer.
QUANTIFICATION AND STATISTICAL ANALYSIS
p values were calculated using unpaired two-sided Mann-Whitney U-test. *p < 0.05, **p < 0.01. N.S. stands for not significant. Error bars represent mean ± SD.
DATA AND SOFTWARE AVAILABILITY
Sequencing data have been deposited into the Gene Expression Omnibus (GEO) under the accession number GEO: GSE102040. Original imaging data have been deposited to Mendeley Data and are available at https://doi.org/10.17632/bf8cshtzmx.1
ADDITIONAL RESOURCES
A detailed protocol describing m 1 A-MAP used in this study is provided in Methods S1.
